Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Leases (2020 - 2026)

Bioventus filings provide 6 years of Leases readings, the most recent being $15.7 million for Q4 2025.

  • On a quarterly basis, Leases changed 0.11% to $15.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.7 million, a 0.11% change, with the full-year FY2025 number at $15.7 million, changed 0.11% from a year prior.
  • Leases hit $15.7 million in Q4 2025 for Bioventus, up from $11.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $18.7 million in Q2 2022 to a low of $6.6 million in Q1 2025.
  • Median Leases over the past 5 years was $15.7 million (2024), compared with a mean of $15.3 million.
  • Biggest five-year swings in Leases: grew 14.87% in 2021 and later tumbled 52.24% in 2025.
  • Bioventus' Leases stood at $17.2 million in 2021, then decreased by 2.89% to $16.7 million in 2022, then dropped by 14.45% to $14.3 million in 2023, then increased by 10.21% to $15.7 million in 2024, then decreased by 0.11% to $15.7 million in 2025.
  • The last three reported values for Leases were $15.7 million (Q4 2025), $11.6 million (Q3 2025), and $12.0 million (Q2 2025) per Business Quant data.